Oxymorphone Hydrochloride Extended Release Articles
US FDA to allow generic copies of Endo's Opana
13 May 2013
Endo fails in FDA law suit to stop generic Opana ER in USA; Mylan settles with Orion
21 December 2012
US FDA clears Mylan’s generic versions of Hyzaar and Cozaar and Watson’s copy of Lotrel; Watson settles with Endo
18 October 2010
Forest/Merz settle with Mylan and others of generic Namenda; Impax’ generic Opana cleared in USA
23 July 2010
Endo/Penwest settle Opana litigation
2 March 2009
FDA clears three new Opana ER strengths
10 March 2008
Showing 1-7 of 7 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
